A recent study conducted in Boston, MA, found patients appear to live longer and have a reduced incidence of Alzheimer's disease and related dementias (ADRD) after BCG vaccine treatment.
This Original Investigation was published by the peer-review journal The JAMA Network Open on May 19, 2023, and found the 100-year-old Bacillus Calmette-Guérin (BCG) vaccine was associated with a reduced risk of Alzheimer's disease and related dementias.
Old Vaccine Associated with a Significantly Lower Rate and Risk of Alzheimer Disease and Related Dementias
Low Risk of Recurrent Thrombotic Events After COVID-19-Linked VTE
Risk of recurrent thrombotic events similar to that of patients with VTE linked to hospitalization for other acute medical illness